---
$id: https://graph.org.ai/products/commodity/51151661
$type: Product
source: UNSPSC
code: "51151661"
title: "Solifenacin"
class: "51151600"
classTitle: "Cholinergic blocking agents"
family: "51150000"
familyTitle: "Autonomic nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Solifenacin

**UNSPSC Code**: 51151661
**Class**: [Cholinergic blocking agents](Cholinergic blocking agents.mdx)
**Family**: [Autonomic nervous system drugs](../Autonomic nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antimuscarinic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier A8910SQJ1U. European Medicines Agency schedules Solifenacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB21589. Solifenacin generally arises in the molecular formula C23H26N2O2. The term SOLIFENACIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16., no. 1.2002, list 47.) Most nations schedule solifenacin under HS 29334990 and SITC 51575. As of Q4 2014, SOLIFENACIN remains the US FDA Preferred Term for this commodity. Solifenacin bears US NLM identifiers UMLS ID C1099677 and NCI Concept Code C75284. SMILES: O(C1C2CCN(C1)CC2)C(=O)N1C(c2c(CC1)cccc2)c1ccccc1.OC(=O)CCC(=O)O.

